Medicine
Photrexa Cross-linking Kit kit
Photrexa Cross-linking Kit kit is a prescription medicine containing Riboflavin 5-phosphate ophthalmic, marketed by Glaukos, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Kits should be stored at 2°C to 8°C (36°F to 46°F).
Key facts
- Active ingredient (INN)
- Riboflavin 5-phosphate ophthalmic
- Brand
- Photrexa Cross-linking Kit
- Dosage form
- Kit
- Packs
- 2 pouches
- Marketing authorisation holder
- Glaukos
- Manufacturer
- Glaukos
- Origin register
- US FDA, United States
- Storage
- Kits should be stored at 2°C to 8°C (36°F to 46°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 25 September 2017
- Identifiers
- RxCUI 1925825, 1925830DailyMed set ID f82cfe92-1a24-11e3-8ffd-0800200c9a66NDC 25357-025Application NDA203324
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 2 pouch in 1 box / 1 pouch in 1 pouch / 1 syringe, glass in 1 pouch / 1 kit in 1 syringe, glass | 25357-025-03 | Glaukos | 25 September 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Riboflavin 5-phosphate ophthalmic kit.
Clinical summary
Riboflavin 5-phosphate ophthalmic is a prescription medicine indicated in corneal collagen cross-linking, among other approved uses. It is available as kits for ophthalmic use. MedsAcross supplies Riboflavin 5-phosphate ophthalmic for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Riboflavin 5-phosphate ophthalmicFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Photrexa Cross-linking Kit prescribing information (Glaukos) · U.S. National Library of Medicine, DailyMed
Need Photrexa Cross-linking Kit kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.